Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|October 26, 2020

Diagnostic Imaging's A Look Ahead: Oct. 26, 2020, to Nov. 1, 2020

Here's what to expect this week on Diagnostic Imaging.

In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:

Breast Cancer Awareness month will soon be coming to a close, but that does not mean radiology practices and breast imaging centers should relax the attention they pay to patients who come in for breast cancer screening. This week, Diagnostic Imaging spoke with breast imaging technologist Stephanie Johnston from Solis Mammography in Texas about what is most important to women when they come in for annual screening, as well as what practices can do to ensure women have the best counters possible.

For additional insights on patient experience, click here.

For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.

Stroke remains the leading cause of disability in the United States, as well as a leading cause of death. Given their skill set, radiologists are uniquely positioned for stroke prevention. In a column this week, Diagnostic Imaging Editorial Board member Mina Makary, M.D., an interventional radiologist from The Ohio State University Wexner Medical Center, shared insights on alternative training models for interventional neuroradiology.

To read our previous coverage of neuroimaging, click here.

Research efforts are continuing to help providers better understand the development of dementia in patients. This week, we will share investigation results from two institutions that shed light on how this disease affects the brain. Look for this coverage as the week progresses.

To read Diagnostic Imaging’s dementia coverage, click here.


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Radiology and Building the Alzheimer’s Care Pathway of the Future
Given the increasing prevalence of Alzheimer’s disease and a staggering number of people with dementia who are undiagnosed, this author discusses five essential keys for radiologists and their colleagues to facilitate earlier detection, precision care treatment and monitoring to help ensure timely care and intervention.